By sucrose density gradient sedimentation analysis, a cytosol component of small molecular size which bound 3H-retinoic acid was detected in the chick embryo brain, exhibiting a peak on day 14 (7 days before hatching). In general, cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) have been distin guished by showing binding specificity for retinol or retinoic acid, respectively. However, the component found in embryo brain cytosol exhibited binding affinity for both retinol and retinoic acid , being similar in less ligand-specificity to CRBP (F) which was originally recognized in fish eye cytosol. Moreover, the component also showed a lack of binding affinity for prealbumin (PA), excluding the possibility that chicken plasma RBP was contaminated in the cytosol. These findings strongly suggest that a distinct molecular species of cellular binding protein for vitamin A exists in the brain cytosol of a developing chick embryo.
(CRABP) has also been detected in a limited number of tissues (i.e., the reproductive organ, eye and brain) of the rat (7), the bovine retina (8) and the chick embryo skin (9) . Moreover, ONG and CHYTIL (10) have recently demonstrated that CRABP, purified from rat testis, has an identical molecular weight, 14,600, to that of rat liver CRBP, but specifically binds retinoic acid on a 1:1 molar basis.
SHIDOJI and MUTO (11) have recently reported that in addition to CRABP, fish eye cytosol contains a distinct binding protein with affinity for both retinol and retinoic acid, that is designated cellular retinol-binding protein, fish-type or CRBP (F). During the course of our studies on vitamin A metabolism in relation to specific binding . proteins of chick embryo (12) , we have incidentally observed a cellular binding component in the chick embryo brain which is similar in molecular size and ligand-specificity to CRBP (F). 666ml: 4g) was used for 1.0ml of each eluate from the gel filtration (counting efficiency, 23%).
MATERIALS AND METHODS

RESULTS AND DISCUSSION
Changes in levels of cellular binding protein labeled with 3H-retinoic acid during embryonic development of the chick brain As previously reported from this laboratory (12), immunoreactive plasma RBP and PA were also found in the chick embryo brain. When both RBP and PA levels were expressed on a basis of per mg cytosol protein, the two proteins exhibited a peak on day 6 (15 days prior to hatching), being consistent with the previous observation (12) . However, the time course of changes in the total contents of RBP and PA were found to be different each other, as shown in Fig. 1 . On embryonic day 14 (7 days before hatching), the brain cytosol contained three times more PA (mol . wt: 55,000) than RBP (mol. wt. 20,000), suggesting an apparent 1:1 molar complex formation similar to that in native plasma. Additional study revealed that immunoreactive RBP and PA were almost quantitatively recovered in the cytosol without previous treatment of Nonidet P-40 for solubilization. By sucrose density gradient sedimentation technique, a cellular binding component labeled with 3H-retinoic acid was detected which had a small molecular size and a low capacity; complete displacement of radioactivity was obtained by adding a 150-fold molar excess over the radioisotope. In sharp contrast to RBP and PA, however, the component in the whole brain exhibited a peak on day 14 (7 days before hatching), as shown at the bottom of Fig. 1 . This result is compatible with the observation made by ONG and CHYTIL (I5) that CRABP of the rat embryo (i.e., liver, lung etc.) decreased and finally disappeared during perinatal development.
Ligand specificity of the cellular binding protein in chick embryo brain: The presence of CRBP (F) Very little is known about CRABP of the chick brain and its perinatal development, with the exception of the previous observation reported by SANI and CORBETT (16) . However, no definite statement was made by these authors with regard to ligand specificity of the CRABP in chick embryo brain. Of great interest is the finding that 3H-retinoic acid bound to a cytosol component of small molecular size (similar to that of myoglobin; mol. wt. 17,800) was displaced not only by unlabeled retinoic acid, but also by retinol at a 150-fold molar excess over the radioisotope by sucrose density gradient centrifugation (Fig. 2) . This unexpected result strongly suggests that brain cytosol contains a different binding protein(s) from either CRABP or CRBP, in terms of ligand specificity.
As already reported (11) , no binding components specific for either retinol or retinoic acid were seen, when native plasma (i.e., a tight complex formation between RBP and PA) was incubated with the labeled vitamins without further purification or pretreatments by organic solvents. Thus, no significant contribution of immunoreactive RBP available in the cytosol is conceivable. However, an attempt was made to eliminate the immunoreactive plasma RBP from the cytosol by human PA-affinity chromatography, and then to examine whether or not a new molecular species of cellular binding protein still remains. As shown in Fig. 3 , elution profiles of gel filtration on Sephadex G-75 clearly demonstrated the presence of a cytosol binding protein with affinity for both retinoic acid and retinol. Moreover, almost all of the radioactivity bound to the specific component (combined fractions of 26 to 31 on the gel filtration, Fig. 3 ) was found to be recovered at the peak 1 (without any affinity for PA), when reexamined by the human PA-affinity chromatography. Preliminary experiments further disclosed that the cytosol component was also labeled with 3H-retinol, and eluted slightly later than CRABP by gel filtration on a longer column of Sephadex G-75, Superfine: the binding protein is assumed to have a smaller molecular size than that of CRABP (Data not shown). In any event, these results strongly suggest the presence of a distinct binding protein in the chick embryo brain which is compatible with CRBP (F) originally recognized in the fish eye cytosol, with special regard to less ligand specificity (11) . Needless to say, further studies are obviously required to isolate and characterize this new molecular species of CRBP (F).
Of additional evidence are the findings in this laboratory that a similar molecular species to CRBP (F) was also detectable in human fetal liver , at a certain phase of regenerating rat liver, and in human hepatocellular carcinoma at much higher levels than those of CRABP (MUTO and OMORI*). Therefore , it is conceivable that CRBP (F) is an ancient protein in phylogenesis as well as an onco-fetal protein in nature. Biological and clinical roles of the protein in cell differentiation and carcinogenesis warrant further exploration.
